[go: up one dir, main page]

AR113793A1 - Proceso para preparar benzotiofen-2-il boronato - Google Patents

Proceso para preparar benzotiofen-2-il boronato

Info

Publication number
AR113793A1
AR113793A1 ARP180103104A ARP180103104A AR113793A1 AR 113793 A1 AR113793 A1 AR 113793A1 AR P180103104 A ARP180103104 A AR P180103104A AR P180103104 A ARP180103104 A AR P180103104A AR 113793 A1 AR113793 A1 AR 113793A1
Authority
AR
Argentina
Prior art keywords
formula
compound
react
allowed
thf
Prior art date
Application number
ARP180103104A
Other languages
English (en)
Inventor
Platzek Johannes Dr
Gries Jrg Dr
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60293714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR113793(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of AR113793A1 publication Critical patent/AR113793A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un proceso para preparar el benzotiofen-2-il boronato de fórmula (1) que sirve como intermediario para la producción de medicamentos y para la producción de medicamentos para el tratamiento y/o la profilaxis de trastornos proliferativos, como, por ejemplo, cáncer y enfermedades tumorales. Reivindicación 1: Un método de preparación de un compuesto de fórmula (1), caracterizado porque comprende los siguientes pasos: paso 5: en el que un compuesto de fórmula (2) se deja reaccionar, mediante la disolución de un compuesto de fórmula (2) en un solvente inerte como, por ejemplo, THF, y la adición de una base orgánica de metal como, por ejemplo, una solución de n-butil litio y un borato de trialquilo como, por ejemplo, borato de triisopropilo, opcionalmente en un solvente, como, por ejemplo, THF, con lo cual se proporciona un compuesto de fórmula (1); dicho compuesto de fórmula (2) se prepara mediante el siguiente paso 4: en el que un compuesto de fórmula (3), se deja reaccionar, opcionalmente en presencia de un solvente inerte, como, por ejemplo, THF, con uno o más agentes reductores, como, por ejemplo, una solución de sodio-bis(2-metoxi-etoxi)-aluminio-dihidruro, con lo cual se proporciona un compuesto de fórmula (4) y se deja reaccionar el compuesto de fórmula (4) con HCl acuoso en presencia de un solvente como, por ejemplo, tolueno, con lo cual se proporciona un compuesto de fórmula (5); y se deja reaccionar el compuesto de fórmula (5) con uno o más agentes reductores, como, por ejemplo, una solución de sodio-bis(2-metoxi-etoxi)-aluminio-dihidruro, con lo cual se proporciona un compuesto de fórmula (2).
ARP180103104A 2017-10-25 2018-10-25 Proceso para preparar benzotiofen-2-il boronato AR113793A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17198336 2017-10-25

Publications (1)

Publication Number Publication Date
AR113793A1 true AR113793A1 (es) 2020-06-10

Family

ID=60293714

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180103104A AR113793A1 (es) 2017-10-25 2018-10-25 Proceso para preparar benzotiofen-2-il boronato

Country Status (20)

Country Link
US (2) US11274110B2 (es)
EP (1) EP3700894A1 (es)
JP (1) JP2021500392A (es)
KR (1) KR20200074128A (es)
CN (1) CN111225907B (es)
AR (1) AR113793A1 (es)
AU (1) AU2018354780A1 (es)
BR (1) BR112020008063A2 (es)
CA (1) CA3084755A1 (es)
CL (1) CL2020001093A1 (es)
CO (1) CO2020004984A2 (es)
IL (1) IL273952A (es)
JO (1) JOP20200090A1 (es)
MX (1) MX2020004285A (es)
PE (1) PE20211268A1 (es)
SG (1) SG11202002199RA (es)
TW (1) TWI784074B (es)
UA (1) UA126592C2 (es)
UY (1) UY37949A (es)
WO (1) WO2019081346A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
AU2021353004A1 (en) 2020-09-30 2023-04-13 Nobell Foods, Inc. Recombinant milk proteins and food compositions comprising the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030355A1 (it) * 2003-07-18 2005-01-19 Sigma Tau Ind Farmaceuti Composti ad attivita' citotossica derivati della combretastatina.
CA2676906A1 (en) * 2007-02-12 2008-08-21 Intermune, Inc. Novel inhibitors hepatitis c virus replication
CA2739058A1 (en) * 2008-10-15 2010-04-22 Kissei Pharmaceutical Co., Ltd. Fused heterocyclic derivative and use thereof for medical purposes
UY34484A (es) 2011-12-15 2013-07-31 Bayer Ip Gmbh Benzotienilo-pirrolotriazinas disustituidas y sus usos
US9598416B2 (en) * 2011-12-15 2017-03-21 Bayer Intellectual Property Gmbh Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancer

Also Published As

Publication number Publication date
PE20211268A1 (es) 2021-07-19
RU2020115600A3 (es) 2022-03-29
BR112020008063A2 (pt) 2020-11-03
US11274110B2 (en) 2022-03-15
JP2021500392A (ja) 2021-01-07
US20200339606A1 (en) 2020-10-29
JOP20200090A1 (ar) 2020-05-03
CN111225907B (zh) 2023-05-26
AU2018354780A1 (en) 2020-04-09
WO2019081346A1 (en) 2019-05-02
TWI784074B (zh) 2022-11-21
UY37949A (es) 2019-05-31
CN111225907A (zh) 2020-06-02
UA126592C2 (uk) 2022-11-02
CA3084755A1 (en) 2019-05-02
RU2020115600A (ru) 2021-11-25
CL2020001093A1 (es) 2020-10-23
US20220356194A1 (en) 2022-11-10
IL273952A (en) 2020-05-31
MX2020004285A (es) 2020-07-29
CO2020004984A2 (es) 2020-05-05
TW201925211A (zh) 2019-07-01
EP3700894A1 (en) 2020-09-02
KR20200074128A (ko) 2020-06-24
SG11202002199RA (en) 2020-04-29

Similar Documents

Publication Publication Date Title
AR113793A1 (es) Proceso para preparar benzotiofen-2-il boronato
BR112018011929A2 (pt) composto, composição farmacêutica, métodos para tratamento da infecção viral da hepatite c, de carcinoma basocelular, de ceratose actínica, da infecção viral de papiloma genital e da infecção viral de hepatite c, processo para preparação de um composto, e, uso de um composto
MX350539B (es) Compuestos de enediino, conjugados de los mismos y sus usos y metodos.
ECSP20029790A (es) Compuestos moduladores de sting y métodos de elaboración y uso
AR110460A1 (es) Proceso para preparar terpinen-4-ol
MY179194A (en) Process for preparing therapeutic nanoparticles
PE20150966A1 (es) Compuestos heteroaromaticos y su uso como ligandos d1 de dopamina
PE20191685A1 (es) Procesos para la preparacion de un agente inductor de la apoptosis
MX2015012731A (es) Procesos e intermedios para preparar un medicamento.
JO3092B1 (ar) مركب لتحفيز مسيطر عليه للمبيض
PH12016500967A1 (en) Functionalised and substituted indoles as anti-cancer agents
AR110461A1 (es) Proceso para preparar una mezcla de alcoholes de terpeno
SA515370018B1 (ar) مركب سائل أيوني
AR105176A2 (es) Procedimiento para preparar una sal de tipo camsilato
MX2013014421A (es) Procedimiento para la preparacion de una composicion que comprende complejos metalicos en una matriz organica aceitosa.
MX347882B (es) Procedimiento mejorado para preparar (3e, 7e)-homofarnesol.
MY183427A (en) A method for producing 2-fluoro-4-borono-l-phenylalanine, and precursor of 2-fluoro-4-borono-l-phenylalanine
AU2014246723A8 (en) A method of preparing pure precious metal nanoparticles with large fraction of (100) facets, nanoparticles obtained by this method and their use
PH12016502158B1 (en) Preparation method of a catalyst component for olefin polymerization
UY36746A (es) Método para la síntesis de derivados de rapamicina
SV2017005520A (es) Derivados de tetrahidropiranil benzamida
AR104345A1 (es) Proceso para preparar un artículo fabricado de poliolefina
MX2015017198A (es) Matriz.
PH12016501808A1 (en) Chemical compounds
NZ710106A (en) A fungicidal composition

Legal Events

Date Code Title Description
FA Abandonment or withdrawal